The process of skin carcinogenesis in mice can be effected by (PROD) were examined for their effects on formation of using either a complete carcinogenesis protocol (one large ,12-dimethylbenz[a]anthraapplied at doses of 400 nmol. These two coumarins also cene (DMBA) have been identified as effective tumor initiators inhibited B[a]P-DNA adduct formation at similar doses and complete carcinogens in the mouse skin model, with the but to a lesser extent. Imperatorin at a dose of 400 nmol latter compound being particularly potent in this regard (1-3). dramatically decreased formation of covalent DNA adducts These polycyclic aromatic hydrocarbons (PAH) are metaderived from both the anti and syn diol epoxides of DMBA.
Introduction be potent inhibitors of mouse hepatic ethoxyresorufin-Odeethylase (EROD) and/or pentoxyresorufin-O-dealkylase
The process of skin carcinogenesis in mice can be effected by (PROD) were examined for their effects on formation of using either a complete carcinogenesis protocol (one large benzo cancer; cigarette-induced lung cancer). During the initiation a dose of 400 nmol also significantly reduced total covalent stage, carcinogens are metabolically activated to form ultimate binding of B[a]P by 59%. In addition, formation of the carcinogens, which react with DNA at critical target genes major (⍣)anti-B[a]P-diol epoxide-N2-dGuo adduct was such as the c-Ha-ras protooncogene resulting in mutations (1) . selectively reduced by both of these coumarins. In contrast,
Since the initiation stage is irreversible, inhibition of the bergamottin and coriandrin did not significantly decrease formation of carcinogen-DNA adducts, in theory, should covalent binding of DMBA to epidermal DNA at doses of reduce the formation of tumors. Many chemicals have been either 400 nmol or 800 nmol. Imperatorin and isopimpinelshown capable of inhibiting the tumor initiation stage of lin, which are more potent inhibitors of hepatic PROD chemical carcinogenesis in mouse skin as well as other model activity, significantly reduced overall binding of DMBA to systems (reviewed in 1-3) supporting this hypothesis. epidermal DNA by 67% and 52%, respectively, when Benzo[a]pyrene (B[a]P*) and 7,12-dimethylbenz [a] anthraapplied at doses of 400 nmol. These two coumarins also cene (DMBA) have been identified as effective tumor initiators inhibited B[a]P-DNA adduct formation at similar doses and complete carcinogens in the mouse skin model, with the but to a lesser extent. Imperatorin at a dose of 400 nmol latter compound being particularly potent in this regard (1) (2) (3) . dramatically decreased formation of covalent DNA adducts These polycyclic aromatic hydrocarbons (PAH) are metaderived from both the anti and syn diol epoxides of DMBA.
bolically activated by cytochrome(s) P450 to diol-epoxide Bergamottin was a potent inhibitor of tumor initiation by intermediates (4). The major DNA adducts derived from B[a]P B[a]P while coriandrin was less effective in this regard.
are formed by reaction of (ϩ)anti-B[a]P-diol epoxide [(ϩ)antiImperatorin was an effective inhibitor of skin tumor initi-BPDE] with deoxyguanosine (dGuo) or from DMBA by ation by DMBA and also inhibited complete carcinogenesis reaction of both the anti-or syn-DMBA-diol epoxides (antiby this PAH. At dose levels higher than those effective DMBADE or syn-DMBADE) with dGuo and/or deoxyadenosagainst DMBA, imperatorin also inhibited tumor initiation ine (dAdo) (5, 6) . It has been shown that the formation of some by B[a]P. The results demonstrate that several naturally of these DNA adducts are quantitatively correlated with the occurring coumarins possess the ability to block DNA tumor initiating activity of these PAH (7, 8 inhibited the formation of DNA adducts and also inhibited BPDE-N2-dGuo adduct and a DNA adduct that cochromatographed with a marker adduct derived from further metabolism of 9-OH-B[a]P. This adduct was tentatively identified as a 9-OH-4,5-oxide-B[a]P-dGuo adduct (Table II) . Bergamottin inhibited formation of (ϩ) anti-BPDE-N2-dGuo by 80% and inhibited formation of 9-OH-4,5-oxide B[a]P-dGuo by 90%. individual DMBA-DNA adducts in mouse epidermis is shown Table III . Bergamottin and coriandrin, neither of which significantly inhibited total DMBA-DNA adducts at a dose of 400 nmol, did lower the level of both the anti-DMBADEof DMBA to DNA at doses from 20 nmol to 800 nmol per mouse. On the other hand, imperatorin inhibited covalent dGuo and dAdo adducts by~40%. However, the level of the major syn-DMBADE-dAdo adduct was enhanced by binding of both B[a]P and DMBA to DNA in a dose-dependent manner. As observed in the initial studies with a single dose pretreatment with bergamottin (48%) or coriandrin (18%). Imperatorin, which efficiently inhibited total DMBA-DNA of imperatorin (Table I) , a differential inhibitory effect was also observed with this compound depending on whether B[a]P adducts at a dose of 400 nmol per mouse, significantly decreased formation of all three major DMBA-DNA adducts. or DMBA was used. In this regard, at all doses tested imperatorin reduced covalent binding of DMBA to a greater Two weeks later, mice were treated with twice-weekly applicaadducts in mouse epidermis. For these experiments, DNA adduct samples were obtained from mice treated with 400 tion of TPA (1.7 nmol). Tumors were recorded weekly starting in week 6 after initiation (i.e. week 4 of promotion). The nmol of the specific coumarins. Bergamottin, coriandrin, and ostruthin significantly decreased formation of the (ϩ) antieffects of bergamottin, coriandrin, ostruthin, and imperatorin Control mice that received acetone, bergamottin (800 nmol), ostruthin (1200 nmol), or imperatorin (1600 nmol) only at initiation had 0.17 (10%), 0.17 acetone, bergamottin (800 nmol), ostruthin (1200 nmol), or imperatorin (1600 nmol) only at initiation had 0.17 (10%), 0.17 (14%), 0.23 (13%), or (14%), 0.23 (13%), or 0.11 (11%), respectively, papillomas per mouse (numbers in parentheses represent papilloma incidence). 0.11 (11%), respectively, papillomas per mouse (numbers in parentheses represent papilloma incidence).
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Materials
b Significantly less than the control receiving acetone in the place of coumarins based on Wilcoxon rank sum test with P Ͻ 0.05. b Significantly less than the control receiving acetone in the place of coumarins based on Wilcoxon rank sum test with P Ͻ 0.05. Table V. In the first experiment shown in Table V , none of on tumor initiation by B[a]P are summarized in Table IV . As these coumarins inhibited tumor initiation by DMBA; however shown in Table IV , bergamottin inhibited tumor initiation by bergamottin, significantly enhanced tumor initiation at both B[a]P in a dose-dependent manner. Even the lowest dose of 400 nmol (177% of control, P Ͻ 0.05) and 800 nmol (180% bergamottin (20 nmol) reduced the average number of papilof control, P Ͻ 0.05). In a second experiment (Table V) , lomas per mouse at plateau (Table IV) in mice treated with imperatorin effectively inhibited tumor initiation (as indicated B[a]P (~20%) although this reduction was not statistically by a reduction in the average number of papillomas per mouse significant (P Ͼ 0.05). In the group of mice treated with 800 at plateau) by DMBA at both 400 nmol (40%) and 800 nmol nmol bergamottin, an~75% reduction in the average number (69%) doses (Table V) . In addition, ostruthin at a dose of of B[a]P-initiated papillomas was achieved (Table IV) . Table  1200 nmol also produced a slight inhibition of tumor initiation IV shows the effect of a 400 nmol dose of either coriandrin by DMBA (Table V, 22%) although this effect was not or ostruthin on papilloma formation in mice initiated with 200 statistically significant (P Ͼ 0.05). Finally, bergamottin nmol B[a]P (Experiment I). At this dose, coriandrin caused a enhanced tumor initiation by DMBA (Table V, 39%) which slight reduction in papilloma formation (25%) compared with was again statistically significant (P Ͻ 0.05). the control group, however, this reduction was not statistically
Effect of imperatorin on complete carcinogenesis by DMBA significant (P Ͼ 0.05). At 400 nmol, ostruthin did not produce any inhibitory effect on tumor initiation by B[a]P. In a second
As part of the current study, we also examined the effect of imperatorin on complete carcinogenesis by DMBA. For these experiment, the effect of imperatorin on tumor initiation by B[a]P was examined. In addition, a higher dose of ostruthin experiments, groups of 30 mice were each treated with either DMBA alone (50 nmol) or two doses of imperatorin (400 and was also tested in this experiment. As shown in Table IV , imperatorin at a dose of 1600 nmol produced a 37% inhibition 800 nmol) 5 min prior to topical application of 50 nmol DMBA. All treatments were given once weekly. Imperatorin of tumor initiation by B[a]P that was statistically significant (P Ͻ 0.05) while at 800 nmol had little or no effect. In was chosen for these experiments because it inhibited formation of covalent DNA adducts by both B[a]P and DMBA and it addition, ostruthin at 1200 nmol inhibited papilloma formation by 22% but this effect was not statistically significant. also inhibited tumor initiation by both hydrocarbons. Starting at week nine, the number of tumors per mouse was recorded The effects of imperatorin, bergamottin, coriandrin, and ostruthin on tumor initiation by DMBA are summarized in each week. As shown in Figure 2A , the cumulative number Fig. 3 . Effect of imperatorin on survival rate in complete carcinogenesis by Imperatorin was given 5 min prior to each application of DMBA. Panels A DMBA. u, acetone 0.2 ml ϩ DMBA; e, imperatorin 400 nmol ϩ DMBA; and B represent cumulative papilloma yield and incidence, respectively. and s, imperatorin 800 nmol ϩ DMBA. Panels C and D represent cumulative carcinoma yield and incidence, respectively. u, acetone 0.2 ml ϩ DMBA; e, imperatorin 400 nmol ϩ DMBA; and s, imperatorin 800 nmol ϩ DMBA.
(and in the case of coriandrin human P450 1A1) or PROD activity in vitro (11) were examined for their effects on the of papillomas in the control group of mice treated with acetone formation of DNA adducts in mouse epidermis and on skin and DMBA reached a plateau by the 25th week. Imperatorin tumorigenesis by either B[a]P or DMBA. Imperatorin and at dose levels of 400 nmol and 800 nmol significantly inhibited isopimpinellin were effective and more selective inhibitors DMBA-induced papilloma formation by 76% and 85%, of hepatic PROD activity in vitro (presumably mediated by respectively, at this time. The appearance of papillomas was P450 2b family enzymes) (11), whereas bergamottin and delayed 9 weeks by pretreatment with imperatorin compared coriandrin were more selective inhibitors of hepatic EROD with the control group. Figure 2B shows the percentage of activity in vitro (presumably mediated by P450 1a-1) (11). mice with papillomas as a function of treatment week and also Finally, ostruthin was also included in this study because, indicates the delay in appearance in groups pretreated with the based on its activity against hepatic EROD and PROD coumarin.
in vitro, it was expected to be less effective at inhibiting Figure 2C shows that the number of carcinomas reached tumorigenesis than the other selected coumarins. The major a maximum yield (1.6 carcinomas/mouse) at the 32nd week findings of the current study were as follows: i) the ability in the DMBA only group, whereas only 0.8 carcinomas/ of this group of coumarins to inhibit covalent binding of mouse and 0.5 carcinomas/mouse were present in the B[a]P to DNA and to inhibit tumor initiation by B[a]P imperatorin pretreated groups at 400 nmol and 800 nmol, roughly correlated with their ability to inhibit hepatic EROD respectively. These differences in carcinoma yield were activity in vitro (bergamottin Ͼ coriandrin Ͼ ostruthin ≅ significant (p Ͻ 0.05). A 5 and 7 week delay in the imperatorin); ii) with the exception of bergamottin, the appearance of the first carcinoma was observed in the ability of this group of coumarins to inhibit covalent binding groups treated with 400 nmol and 800 nmol imperatorin, of DMBA and to inhibit tumor initiation by DMBA respectively ( Figure 2D ). In addition, the time to 50% correlated roughly with their ability to inhibit hepatic PROD carcinoma incidence in the DMBA only group was also activity in vitro (imperatorin ≅ isopimpinellin Ͼ ostruthin significantly delayed by imperatorin pretreatment (27 vs 31 Ͼ coriandrin ≅ bergamottin); iii) bergamottin, the compound and 27 vs 33, at the 400 and 800 nmol doses, respectively). most effective against B[a]P DNA adduct formation and Pretreatment with imperatorin also dramatically improved tumor initiation, actually enhanced tumor initiation by survival. In this regard, control mice treated with DMBA DMBA, whereas imperatorin, the compound most effective alone had a TS50 of 29 weeks, while the groups of mice against DMBA DNA adduct formation and tumor initiation, pretreated with 400 nmol or 800 nmol imperatorin has TS50 had less inhibitory activity against tumor initiation by B[a]P; of 35 and 36 weeks, respectively (see Figure 3 and Table  and iv) bergamottin and coriandrin selectively inhibited VI). These differences in survival were highly significant formation of anti-diol-epoxide DNA adducts from both (p Ͻ 0.0001). All of the data from this experiment is B[a]P and DMBA similar to our observations with these summarized in Table VI. compounds in studies using cultured keratinocytes (13). Collectively, the data suggest that the major P450 systems Discussion involved in the metabolic activation of B[a]P and DMBA differ in mouse epidermis. In addition, the data indicate In the present study, several naturally occurring coumarins previously shown to be effective at inhibiting either EROD that certain coumarins have the ability to inhibit tumor initiation by both B[a]P and DMBA and, in the case of significant reduction in tumor yield. Future experiments will explore this possibility in more detail. Nevertheless, the overall imperatorin, inhibit complete carcinogenesis by DMBA.
Inhibition of PAH-induced tumorigenesis by either synthetic effects of this group of coumarins on tumor initiation by B[a]P roughly followed their in vitro potency for inhibition of hepatic or naturally occurring compounds has been widely studied in the past (reviewed in 2 and 3). These modifying agents include:
EROD activity (11) and their ability to reduce B[a]P DNA adduct levels. antioxidants (e.g., BHA, BHT, and selenium), inducers of certain cytochrome(s) P450 (e.g., TCDD and 5,6-BF), and Imperatorin, at 400 nmol and 800 nmol doses, significantly inhibited tumor initiation by DMBA, but was much less inhibitors of certain cytochromes P450 (e.g. imperatorin, at a dose of 1600 nmol, did significantly inhibit tumor initiation by B[a]P supporting this conclusion. Thus, but had little or no effect or, at some doses, actually enhanced tumor initiation by DMBA. In contrast, Alworth et al. (9) the ability of this series of coumarins to inhibit tumorigenesis by DMBA roughly correlated with their ability to inhibit reported that 1-EP inhibited tumor initiation by both B[a]P and DMBA. 1-EP is a mechanism based inactivator of P450 hepatic PROD activity in vitro (9) . The one exception to this latter correlation was bergamottin which, in addition to being 1A1 and P450 1B1, being more potent toward the latter P450 (18) . Compared with 1-EP, bergamottin achieved similar the most potent inhibitor of hepatic EROD activity in vitro (IC50 ϭ 0.12 µM, reference 9), was also a fairly potent inhibition of papilloma formation (75%) at a dose (800 nmol) 5-fold lower than 1-EP indicating that bergamottin was a much inhibitor of hepatic PROD activity in vitro (11). A possible explanation for the lack of effect of bergamottin on DMBA more potent inhibitor of B[a]P tumor initiation than 1-EP. The inhibitory effect of bergamottin on tumor initiation by B[a]P tumor initiation is that this compound was a more potent and selective inhibitor of hepatic EROD. The major P450 mediating correlated with its ability to inhibit formation of B[a]P-DNA adducts, supporting the conclusion that the effect of MC-induced EROD activity, P450 1A1 (or 1a-1 in mouse) appears to be involved in metabolizing DMBA to relatively bergamottin on tumor initiation was due to inhibition of the metabolic activation of B[a]P. The inability of bergamottin to nontoxic metabolites (19, 20) . Thus, bergamottin, by blocking P450 1a-1, may slow the major detoxication route for DMBA inhibit tumor initiation by DMBA was also consistent with its lack of effect on formation of total covalent DNA adducts thus allowing more of this PAH to be available for metabolic activation by other P450s present in mouse epidermis. from DMBA in mouse epidermis in vivo. The ability of bergamottin, coriandrin and ostruthin to inhibit covalent bindAn interesting observation in the current study was that bergamottin and coriandrin reduced formation of ing of B[a]P to DNA (Tables I and II) anti-DMBADE-DNA adducts while increasing formation of syn-DMBADE-DNA adducts (Table III) thereby resulting in for the observation that doses of bergamottin, coriandrin, imperatorin, and ostruthin which produced a statistically signino significant reduction of overall DMBA-DNA adducts at the dose used in these experiments. Several studies have ficant reduction in B[a]P-DNA adduct levels (Table I and Figure 1 ) did not produce a statistically significant reduction suggested that the formation of anti-DMBADE-DNA adducts may require induction of a specific cytochrome P450 (21-in tumor initiation by B[a]P is that there is a threshold effect. In this regard, it may be necessary for total DNA adduct levels 23). For example, metabolism of DMBA in undifferentiated keratinocytes [low aryl hydrocarbon hydroxylase (AHH) to be reduced below a certain level in order to observe a
